Diagnostic tools for filariasis elimination programs

doi:10.1016/j.pt.2006.12.001

Trends in Parasitology

Volume 23, Issue 2, February 2007, Pages 78-82

https://doi.org/10.1016/j.pt.2006.12.001 Get rights and content

The ambitious and exciting Global Programme to Eliminate Lymphatic Filariasis (GPELF) is largely based on a strategy of mass drug administration (MDA) of repeated rounds of antifilarial medications to endemic populations around the world. Diagnostic tools are important to GPELF because they affect decisions regarding where to distribute MDA, how to measure its effects, how to define targets and endpoints for stopping MDA, and how to monitor populations for possible resurgence of filariasis transmission following suspension of MDA. This article reviews available diagnostic tests for filariasis and their potential use as tools for different phases of filariasis elimination programs.

Section snippets

Filariasis elimination and diagnostic tools

Lymphatic filariasis (LF) is caused by the nematode parasites Wuchereria bancrofti, Brugia malayi and Brugia timori and is transmitted by mosquitoes. It is an important cause of physical and social disability that affects over 100 million people in 83 countries in the developing world. Traditional LF control programs were based largely on selective treatment of infected individuals detected by mass screening of blood smears (collected at night) for microfilariae (Mf). Advances in treatment and

Phase 1: mapping and planning PELFs

The first phase of a PELF requires a sensitive, specific and convenient method for detecting LF endemicity that can be used to map endemic areas for inclusion in the program. Overdiagnosis that misclassifies nonendemic areas can greatly increase program expenses and decrease chances for success. Underdiagnosis and exclusion of endemic areas is also not acceptable.

There are several viable diagnostic options for Phase 1 (Box 1). These include: Mf testing, filarial-antigen tests, antibody

Phase 2: monitoring progress during a PELF

Interim assessments are essential to demonstrate progress, to identify problems that can be solved while funding is still available and for securing resources needed to complete a program. Requirements for tools for this purpose are somewhat different from those used for mapping endemicity. Consider Mf testing: microfilaremia prevalence rates and community Mf loads typically decrease within months after initiation of MDA programs. Although this is a positive change and evidence of good MDA

Phase 3: endpoints for PELFs

More information is needed on how to use antigen, antibody and MX tests to inform decisions on when it is safe to discontinue MDA because there is no consensus on this issue at this time. The authors favor an evidence-based approach to this question rather than adoption of arbitrary targets. We do not agree with current WHO guidelines that fail implementation units (requiring additional rounds of MDA) if one in 3000 children born after the initiation of MDA has a positive antigen test [5]. We

Phase 4: post-MDA surveillance and early detection of resurgence

We favor the use of antibody testing and MX as surveillance tools for early detection of resurgent transmission. Large samples are needed to show statistically significant increases in these measures when baseline rates post-cessation of MDA are low. There is no consensus at this time on how these or other tests should be used for post-MDA surveillance. Research is required to provide data on this important question. Surveillance studies in Egypt will repeat assessments in sentinel sites every

Advanced data analysis and modeling

Two recent articles have reviewed the potential value of mathematical modeling as a tool for PELFs 27, 28. Research projects and PELFs around the world are generating reams of data from specific villages, regions and countries. Mathematical analysis and modeling efforts should be expanded to identify patterns in the data so that the field can move from the specific to the general. W. Stolk (personal communication) has commented on this situation as follows: ‘While field studies are useful,

Concluding remarks

GPELF is one of the most ambitious and exciting intervention programs for a neglected tropical disease to date. This review has emphasized how recent advances have increased diagnostic options for filariasis and that different diagnostic tools might be needed for management of different phases of PELFs. More work is needed to fill important gaps in our knowledge regarding the optimal use of these tools (Box 2).

Disclosure statement

The ICT antigen test mentioned in this article uses reagents licensed from Barnes-Jewish Hospital, an affiliation of G. J. Weil. All royalties from sales of this test are donated to the Barnes-Jewish Hospital Foundation, a registered not-for-profit organization (http://www.barnesjewish.org/groups/default.asp?NavID= 1600).

Acknowledgements

This article is based on a working paper presented at the Sixth Meeting of the Technical Advisory Group on the Global Elimination of Lymphatic Filariasis, World Health Organization, Geneva, September 2005. The authors’ filariasis research is supported in part by NIH grant AI 065715.

References (39)

D.H. Molyneux
Vector-borne infections in the tropics and health policy issues in the twenty-first century
Trans. R. Soc. Trop. Med. Hyg.
(2001)
E.A. Ottesen
Lymphatic filariasis: treatment, control, and elimination
Adv. Parasitol.
(2006)
G.J. Weil
Parasite antigenemia in lymphatic filariasis
Exp. Parasitol.
(1990)
G.J. Weil
The ICT filariasis test: a rapid-format antigen test for diagnosis of bancroftian filariasis
Parasitol. Today
(1997)
N. Rahmah
Specificity and sensitivity of a rapid dipstick test (Brugia Rapid) in the detection of Brugia malayi infection
Trans. R. Soc. Trop. Med. Hyg.
(2001)
R.M.R. Ramzy
Effect of yearly mass drug administration with diethycarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment
Lancet
(2006)
E. Michael
Mathematical models and lymphatic filariasis control: endpoints and optimal interventions
Trends Parasitol.
(2006)
M.M. Ismail
Long-term efficacy of single-dose combinations of albendazole, ivermectin, and diethylcarbamazine for the treatment of lymphatic filariasis
Trans. R. Soc. Trop. Med. Hyg.
(2001)
H. Helmy
Bancroftian filariasis: effect of repeated treatment with diethycarbamazine and albendazole on microfilaremia, antigenemia, and anti-filarial antibodies
Trans. R. Soc. Trop. Med. Hyg.
(2006)
R. Ramzy
A polymerase chain reaction-based assay for detection of Wuchereria bancrofti in human blood and Culex pipiens
Trans. R. Soc. Trop. Med. Hyg.
(1997)

A.E. Muck

Influence of infection with non-filarial helminths on the specificity of serological assays for antifilarial immunoglobulin G4

Trans. R. Soc. Trop. Med. Hyg.

(2003)

E.A. Ottesen

Strategies and tools for the control/elimination of lymphatic filariasis

Bull. World Health Organ.

(1997)

World Health Organization

Global Programme to Elimination Lymphatic Filariasis

Wkly. Epidemiol. Rec.

(2006)

World Health Organization (2005) Monitoring and Epidemiological Assessment of the Programme to Eliminate Lymphatic...

G.J. Weil et al.

Identification and partial characterization of a parasite antigen in sera from humans infected with Wuchereria bancrofti

J. Immunol.

(1987)

G.J. Weil

Parasite antigenemia without microfilaremia in bancroftian filariasis

Am. J. Trop. Med. Hyg.

(1996)

S.J. More et al.

A highly sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian filariasis

Trop. Med. Parasitol.

(1990)

G.J. Weil

A monoclonal antibody-based enzyme immunoassay for detecting parasite antigenemia in bancroftian filariasis

J. Infect. Dis.

(1987)

J.O. Gyapong

The use of spatial analysis in mapping the distribution of bancroftian filariasis in four West African countries

Ann. Trop. Med. Parasitol.

(2002)

Cited by (197)

The Filariases
2023, Manson's Tropical Diseases, Fourth Edition
Immunomodulatory effects of chitosan nanoparticles as vaccine delivery agent against lymphatic filariasis through mucosal immunization
2022, International Journal of Biological Macromolecules
Lymphatic filariasis is a parasitic disease caused by nematodes affecting millions of individuals in the tropical region. The complex life cycle of the filarial parasite eludes protective measures such as chemotherapy and vector control. Vaccination through recombinant proteins stands as one of the safe and most effective methods. The filarial antigens Brugia malayi Thioredoxin (TRX) and abundant larval transcript-2 (ALT-2) can induce recognizable levels of protection in murine animal models. Chitosan is a safe, non-toxic material ubiquitously served as an efficient carrier and an adjuvant. The present study was attempted to enhance the immune efficacy of filarial antigens using chitosan nanoparticles (CN) through mucosal routes of immunization. Our study showed that oral immunization was able to produce enhanced humoral response and balanced Th1/Th2 antibody isotype response for the recombinant antigens compared to intranasal routes. A high level of splenocyte T cell proliferation (P < 0.01) was obtained for both routes. The cytokine analysis showed a high level of IFN-γ followed by IL-5 for the oral route, whereas a high level of IL-4 was observed for intranasal route. These results confirm the ability of chitosan nanoparticles to elevate the immune efficacy of the antigens through the oral route in mice.
Filariasis diagnosed by real-time ultrasound scanning as filarial dance sign – A case report
2022, IDCases
Lymphatic filariasis (LF) is a vector-borne illness caused due to Wuchereria bancrofti. Genital abnormalities may result from chronic inflammation of the lymphatic vessels and obstruction of the afferent vessels in Bancroftian filariasis. Doxycycline, albendazole, diethylcarbamazine, and ivermectin are among the treatments available.
A 16-year male presented to our OPD with a complaint of left inguinal swelling for the past 6 Months. Examination of the swelling revealed a left-sided inguinal swelling of 5 × 4 cm with intact overlying skin. A provisional diagnosis of inguinal lymph varix was made, and real-time ultrasound scanning along with FNAC was performed. Swelling resolved after conservative management.
Ultrasonography can easily observe adult worms due to their size and fast movements. Using pulsed-wave doppler mode, the characteristic movement profile of adult worms in pulsed-wave doppler mode can be distinguished from other movements (e.g., blood in venous vessels).
Ultrasound is the imaging modality of choice to detect filarial worms/microfilaria in the lymphatic system, which produces the classic twirling of microfilaria in the lymphatic system, known as the "filarial dance sign".
The story of Lymphatic Filariasis elimination as a public health problem from Yemen
2020, Acta Tropica
In 2000, Yemen joined the WHO global efforts to eliminate lymphatic filariasis (LF) as a public health problem by initiating a National LF Elimination Programme (NLFEP), that was fully integrated with the National Leprosy Elimination Programme (NLEP), the Ministry of Public Health and Population. This article reviews the NLFEP extensive efforts and interventions to eliminate LF in Yemen. LF mapping was started in 2000, followed by five annual rounds of mass drug administration (MDA) with ivermectin and albendazole in 8 implementation units (IUs) during 2002-2006. The epidemiological coverage for all MDA rounds was ≥80%. Based on WHO guidelines of 2005, MDA was stopped in 7 IUs, additional MDA rounds were continued in one IU until 2011. Microfilaremia monitoring and evaluation, and MDA stopping surveys were conducted based on WHO guidelines of 2005 and 2011. Information about the presence of patients suffering from lymphoedema/elephantiasis and hydrocele was collected, and basic care provided to all chronic cases by NLEP coordinators, trained on LF morbidity management and disability prevention (MMDP). As of 2017, a total of 610 lymphoedema patients were trained on self-management, and 31 hydrocele patients were referred to local General Hospitals for surgery. The NLFEP made excellent progress due to integration with NLEP, strong collaboration with national and international bodies, intensive training and supervision, and the use of robust advocacy for mobilization of endemic communities. Transmission assessment surveys (TAS), conducted in 2013 and 2016, indicated 0% antigenemia levels in schoolchildren in the 8 IUs. Thus, after almost two decades of sustained effort, Yemen met the WHO criteria for successful elimination of LF as a public health problem. In 2019, WHO validated Yemen as the second country in the WHO’ Eastern Mediterranean Region to successfully eliminate LF as a public health problem.
Clinical, serological and DNA testing in Bengo Province, Angola further reveals low filarial endemicity and opportunities for disease elimination
2020, Parasite Epidemiology and Control
Citation Excerpt :
To overcome the limitations of conventional microscopic diagnosis for filarial species identification, serological and molecular diagnosis methods have been used as alternatives with varying levels of success (World Health Organization, 2012a; Molyneux et al., 2016). In 2014, the main alternative method to serodiagnosis of loiasis was laboratory-based polymerase chain reaction (PCR), for onchocerciasis the enzyme-linked immunosorbent assay (Ov16 ELISA) and for LF the rapid diagnostic immunochromatographic test (ICT) and laboratory-based PCR (Weil and Ramzy, 2007; Kelly-Hope et al., 2018a). Of note, these alternative methods are yet to be used in conjunction with one another and none have not been used so far in Angola.
The prevalence of Loa loa, Onchocerca volvulus and Wuchereria bancrofti infections in an under-surveyed area of Bengo Province, Angola, was determined by surveying 22 communities with a combination of clinical, serological and DNA diagnostics. Additional information was collected on participants' duration of residency, access to mass drug administration, knowledge of insect vectors and use of bednets. A total of 1616 individuals (38.1% male: 61.9% female), with an average age of 43 years, were examined. For L. loa, 6.2% (n = 100/16616) individuals were found to have eyeworm, based on the rapid assessment procedure for loiasis (RAPLOA) surveys, and 11.5% (n =178/1543) based on nested PCR analyses of venous blood. L. loa prevalences in long-term residents (>10 years) and older individuals (>60 years) were significantly higher, and older men with eyeworm were better informed about Chrysops vectors. For O. volvulus, 4.7% (n = 74/1567) individuals were found to be positive by enzyme-linked immunosorbent assay (Ov 16 ELISA), with only three individuals reporting to have ever taken ivermectin. For W. bancrofti, no infections were found using the antigen-based immunochromatographic test (ICT) and real-time PCR analysis; however, 27 individuals presented with lymphatic filariasis (LF) related clinical conditions (lymphoedema = 11, hydrocoele = 14, both = 2). Just under half (45.5%) of the participants owned a bednet, with the majority (71.1%) sleeping under it the night before. Our approach of using combination diagnostics reveals the age-prevalence of loiasis alongside low endemicity of onchocerciasis and LF. Future research foci should be on identifying opportunities for more cost-effective ways to eliminate onchocerciasis and to develop innovative surveillance modalities for clinical LF for individual disease management and disability prevention.
Characterization of glycan determinants that mediate recognition of the major Wuchereria bancrofti circulating antigen by diagnostic antibodies
2020, Molecular and Biochemical Parasitology
The Global Program to Eliminate Lymphatic Filariasis (GPELF) relies heavily on a rapid diagnostic test (RDT) to a Wuchereria bancrofti circulating filarial antigen (Wb-CFA) to identify endemic areas and for determining when mass drug administration can stop. The antigen contains a carbohydrate epitope that is recognized by monoclonal antibody AD12. Og4C3, a monoclonal antibody that is used in a commercial ELISA for Wb-CFA recognizes the same moiety. Despite its diagnostic importance, little is known about the structure and function of this “AD12 epitope”. It is also present on other W. bancrofti glycoproteins and on glycoproteins of other filarial worms, but such antigens are not detected in the sera of individuals with most other filarial infections. We report here functional and biochemical analyses that shed light on the interaction between filarial glycoproteins and AD12 and/or Og4C3. Binding of these monoclonal antibodies to a mammalian glycan array suggests the reactive moiety has structural similarity to terminal β-d-glucuronic acid in a 1–3 linkage to other hexoses. However, sera collected from individuals with patent W. bancrofti infection had very low or undetectable serum antibodies to the GlcA-containing array glycans. Unlike other filarial glycoproteins, the Wb-CFA is relatively resistant to protease digestion by pronase and trypsin and completely resistant to the mucinase O-sialoglycoprotein endopeptidase (OSGE). The protease resistance of the Wb-CFA may contribute to its consistent detection in Wb-infected sera.

View all citing articles on Scopus

View full text

Trends in Parasitology

ReviewDiagnostic tools for filariasis elimination programs

Section snippets

Filariasis elimination and diagnostic tools

Phase 1: mapping and planning PELFs

Phase 2: monitoring progress during a PELF

Phase 3: endpoints for PELFs

Phase 4: post-MDA surveillance and early detection of resurgence

Advanced data analysis and modeling

Concluding remarks

Disclosure statement

Acknowledgements

Trans. R. Soc. Trop. Med. Hyg.

Adv. Parasitol.

Exp. Parasitol.

Parasitol. Today

Trans. R. Soc. Trop. Med. Hyg.

Lancet

Trends Parasitol.

Trans. R. Soc. Trop. Med. Hyg.

Trans. R. Soc. Trop. Med. Hyg.

Trans. R. Soc. Trop. Med. Hyg.

Trans. R. Soc. Trop. Med. Hyg.

Strategies and tools for the control/elimination of lymphatic filariasis

Bull. World Health Organ.

Global Programme to Elimination Lymphatic Filariasis

Wkly. Epidemiol. Rec.

Identification and partial characterization of a parasite antigen in sera from humans infected with Wuchereria bancrofti

J. Immunol.

Parasite antigenemia without microfilaremia in bancroftian filariasis

Am. J. Trop. Med. Hyg.

A highly sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian filariasis

Trop. Med. Parasitol.

A monoclonal antibody-based enzyme immunoassay for detecting parasite antigenemia in bancroftian filariasis

J. Infect. Dis.

The use of spatial analysis in mapping the distribution of bancroftian filariasis in four West African countries

Ann. Trop. Med. Parasitol.

Review
Diagnostic tools for filariasis elimination programs